Norway · Delayed Price · Currency is NOK Yara International ASA Earnings Call Transcripts
Fiscal Year 2026
-
EBITDA rose 40% year-over-year to $896 million, driven by higher nitrogen margins and strong commercial execution amid significant market disruption from the Middle East conflict. Return on invested capital doubled to 12.2%, and free cash flow increased, with robust operational performance and disciplined capital allocation.
-
The company targets EBITDA improvements of $200 million by 2027 and $350 million by 2030, driven by operational excellence, flexible sourcing, and premium product growth. Decarbonization, regulatory adaptation, and strategic partnerships underpin future value creation, with a strong balance sheet and disciplined capital allocation supporting shareholder returns.
Fiscal Year 2025
-
Strong Q4 European sales were driven by pre-CBAM buying, while Americas remained flat. Maintenance CapEx will rise in 2026 due to larger turnarounds, and working capital is expected to normalize as the season progresses. CBAM and global nitrogen market tightness remain key themes.
-
EBITDA and net income rose sharply year-over-year, driven by cost reductions, record production, and strong market demand. Tight global nitrogen markets and disciplined capital allocation support a positive outlook, with a proposed NOK 22/share dividend for 2025.
-
Stable demand and improved NPK sales in Brazil, with European prices steady and CBAM set to impact future costs. Q3 margins benefited from high phosphate prices, while cost reduction and portfolio optimization continue. Uncertainty remains around CBAM implementation and farmer affordability.
-
Record operational performance drove a 38% year-over-year EBITDA increase and strong ROIC, with cost and CapEx reductions ahead of target. Segment results were robust across regions, though farmer profitability and regulatory changes pose risks.
-
Market share gains in Europe, asset optimization, and strong NPK margins highlighted the quarter. CapEx guidance was reduced, with no equity issuance planned for blue ammonia projects and continued focus on cost improvements.
-
Q2 delivered a 27% year-over-year EBITDA increase and more than tripled adjusted EPS, driven by cost reductions, strong commercial execution, and supportive market fundamentals. CapEx guidance was cut by $250M, and ROIC neared the 10% target.
-
Progress continues on ammonia decarbonization with regulatory incentives and internal offtake as key drivers. Market development for low-carbon fertilizers relies on partnerships and certification, while downstream emissions are addressed through efficiency and inhibitors. CSRD/ESRS reporting is prioritized, and technology neutrality guides the transition plan.
-
Strong Q1 performance driven by European market share gains, cost savings, and robust North American demand. Strategic projects like Sluiskil CCS and blue ammonia remain on track, while Chinese export policy and energy prices pose key uncertainties.
-
EBITDA excluding special items rose 47% year-over-year, driven by strong volumes, improved margins, and cost reductions. Return on invested capital and cash flow improved, with cost and capex reduction programs on track. Nitrogen market fundamentals remain strong.
Fiscal Year 2024
-
Clean ammonia project FID delayed to 2026 due to technical reasons, with profitability outlook unchanged. Cost reduction and working capital optimization remain priorities, while dividend payout is lowered to maintain leverage. Market fundamentals for nitrogen and agriculture remain supportive.
-
Record-high production and safety, $90M in fixed cost reductions, and strong operational performance partly offset lower nitrogen prices, resulting in a 10% drop in EBITDA. Net income was flat year-over-year due to one-offs, while market fundamentals for 2025 remain strong.
-
Q3 saw margin improvements in phosphate, potash, and Brazil, with production outpacing deliveries due to seasonality. The Porsgrunn green hydrogen project is shelved, while the Sluiskil CCS project remains on track. Fixed cost reductions will accelerate next year.
-
EBITDA rose 47% year-over-year to $585 million, driven by margin improvements and cost reductions, with all-time high ammonia and fertilizer production. Portfolio optimization and cost-cutting remain priorities amid tightening nitrogen markets and ongoing European challenges.
-
Q2 was marked by Brazil flooding impacts, early cost savings, and progress on decarbonization projects. The company targets $150M in fixed cost reductions, expects most savings in 2025, and sees solid nitrogen market fundamentals ahead.
-
EBITDA more than doubled year-over-year to $513 million, driven by improved margins and higher deliveries, while a cost and CapEx reduction program targets $300 million in savings by 2025. Flooding in Brazil and high tax rates impacted results, but outlook remains positive amid tightening nitrogen markets.